Literature DB >> 8720615

Insulin analogues and carcinoma of the breast.

P Ebeling, J A Tuominen, V A Koivisto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8720615     DOI： 10.1007/BF00400425

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  15 in total

1.  On the specificity of steroid interaction with mammary glucose 6-phosphate dehydrogenase.

Authors:  R Raineri; H R Levy
Journal:  Biochemistry       Date:  1970-05-26       Impact factor: 3.162

2.  Interorganal relationships of amino acid metabolism in fed rats.

Authors:  H Yamamoto; T Aikawa; H Matsutaka; T Okuda; E Ishikawa
Journal:  Am J Physiol       Date:  1974-06

3.  Enzymes of carbohydrate metabolism in human breast carcinoma: relationship with serum hormones.

Authors:  V Ramalingam; G Krishnamoorthy; P Govindarajulu
Journal:  Neoplasma       Date:  1994       Impact factor: 2.575

4.  The effect of estrogen level on glucose-induced changes in serum insulin-like growth factor binding protein-1 concentration.

Authors:  H Martikainen; R Koistinen; M Seppälä
Journal:  Fertil Steril       Date:  1992-09       Impact factor: 7.329

5.  Antiproliferative effects of the somatostatin analogue octreotide (SMS 201-995) on ZR-75-1 human breast cancer cells in vivo and in vitro.

Authors:  G Weckbecker; R Liu; L Tolcsvai; C Bruns
Journal:  Cancer Res       Date:  1992-09-15       Impact factor: 12.701

6.  Mitogenic action of insulin-like growth factor-I on human osteosarcoma MG-63 cells and rat osteoblasts maintained in situ: the role of glucose-6-phosphate dehydrogenase.

Authors:  C Farquharson; J Milne; N Loveridge
Journal:  Bone Miner       Date:  1993-08

7.  Influence of portal delivery of insulin on intracellular glucose and lipid metabolism.

Authors:  K Falholt; R Cutfield; R Alejandro; A Vølund; L G Heding; D H Mintz
Journal:  Metabolism       Date:  1991-02       Impact factor: 8.694

8.  17 beta-estradiol: inducer of uterine hexokinase.

Authors:  J R Valadares; R L Singhal; M R Parulekar
Journal:  Science       Date:  1968-03-01       Impact factor: 47.728

9.  Enhancement of tamoxifen-induced suppression of insulin-like growth factor I gene expression and serum level by a somatostatin analogue.

Authors:  H Huynh; M Pollak
Journal:  Biochem Biophys Res Commun       Date:  1994-08-30       Impact factor: 3.575

10.  Growth factor involvement in the multihormonal regulation of MCF-7 breast cancer cell growth in soft agar.

Authors:  A Manni; C Wright; H Buck
Journal:  Breast Cancer Res Treat       Date:  1991-12       Impact factor: 4.872
View more
  5 in total

1.  Does diabetes therapy influence the risk of cancer?

Authors:  U Smith; E A M Gale
Journal:  Diabetologia       Date:  2009-09       Impact factor: 10.122

2.  Insulin analogues differently activate insulin receptor isoforms and post-receptor signalling.

Authors:  L Sciacca; M F Cassarino; M Genua; G Pandini; R Le Moli; S Squatrito; R Vigneri
Journal:  Diabetologia       Date:  2010-04-28       Impact factor: 10.122

Review 3.  Insulin, insulin receptors, and cancer.

Authors:  R Vigneri; I D Goldfine; L Frittitta
Journal:  J Endocrinol Invest       Date:  2016-07-01       Impact factor: 4.256

4.  Insulin analogs and cancer.

Authors:  Laura Sciacca; Rosario Le Moli; Riccardo Vigneri
Journal:  Front Endocrinol (Lausanne)       Date:  2012-02-10       Impact factor: 5.555

Review 5.  The metabolic and mitogenic properties of basal insulin analogues.

Authors:  Norbert Tennagels; Ulrich Werner
Journal:  Arch Physiol Biochem       Date:  2013-02       Impact factor: 4.076
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.